Brain, Vol. 110, No. 6, 1579-1616, 1987
© 1987 Guarantors of Brain
research-article |
THE ROLE OF NMR IMAGING IN THE ASSESSMENT OF MULTIPLE SCLEROSIS AND ISOLATED NEUROLOGICAL LESIONS
A QUANTITATIVE STUDY
Institute of Neurology and The National Hospitals, Queen Square London
Correspondence to:
Professor W. I. McDonald, Institute of Neurology, Queen Square, London WCIN 3BG.
The form and distribution of MRI abnormalities in 114 patients with clinically definite multiple sclerosis (MS) have been compared with observations on 53 apparently healthy individuals, 129 patients with isolated focal neurological lesions with which MS often presents (51 patients with optic neuritis, 44 with isolated brainstem lesions and 34 with isolated spinal cord syndromes) and 105 patients with disorders which may be confused clinically or radiologically with MS. The latter comprised 55 patients with cerebral vascular disease (including 7 cases of dementia with diffuse white matter disease), 24 with degenerative ataxic disorders, 8 with cerebellar tonsillar ectopia, 7 with sarcoidosis and 11 with a variety of other disorders.
Periventricular abnormalities were found in all but 2 patients with MS and discrete white matter lesions in all but 12. Characteristically the periventricular changes in MS were irregular in outline. Periventricular abnormalities which were often milder and of smooth outline were seen in 37/55 patients with cerebral vascular disease, 9/24 with cerebellar degeneration, 5/7 with sarcoidosis and in 2/3 apparently healthy individuals over the age of 60. The appearances in the 7 cases of dementia resembled those with advanced MS.
Cerebellar and/or brainstem atrophy characteristic of the cerebellar degenerations, in the absence of white matter abnormalities, was helpful in making the distinction from MS. Congenital anomalies and tumours in the region of the brainstem and foramen magnum were readily shown.
More than half the patients with symptoms attributable to isolated focal neurological lesions had additional lesions at presentation. MS cannot be diagnosed in these cases at presentation, but repeat scans after 5 to 20 months in 25 patients with optic neuritis and 10 with clinically isolated brainstem lesions have shown new lesions in 7 (20%). The patients with new lesions fulfil the criteria for clinically probable MS (Poser et al., 1983).
Measurements of T1, and T2 in vivo permitted the distinction of acute from chronic brainstem lesions. There were quantitative differences in T1, and T2 between the normal appearing white matter in MS and normal brain. Studies of postmortem brains provided convincing evidence that the MRI abnormalities in MS correspond with plaques. Evidence is adduced to support the view that an important source of the abnormal NMR signals in acute lesions is oedema, and in chronic lesions is gliosis; demyelination per se is unlikely to make an important contribution.
Received December 23, 1986. Revised March 4, 1987. Accepted March 12, 1987.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
O. Garcea, A. Villa, F. Caceres, T. Adoni, M. Alegria, R. Barbosa Thomaz, R. Buzo, L. Llamas Lopez, and M. Rivera Kindel Early treatment of multiple sclerosis: a Latin American Experts Meeting Multiple Sclerosis, October 1, 2009; 15(3_suppl): S1 - S12. [Abstract] [PDF] |
||||
![]() |
Y. He, A. Dagher, Z. Chen, A. Charil, A. Zijdenbos, K. Worsley, and A. Evans Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load Brain, May 12, 2009; (2009) awp089v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Miller, B. Weinshenker, M Filippi, B. Banwell, J. Cohen, M. Freedman, S. Galetta, M Hutchinson, R. Johnson, L Kappos, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach Multiple Sclerosis, November 1, 2008; 14(9): 1157 - 1174. [Abstract] [PDF] |
||||
![]() |
N. Venkatanarasimha, W. Mukonoweshuro, and J. Jones AJR Teaching File: Symmetric Demyelination Am. J. Roentgenol., September 1, 2008; 191(3_Supplement): S34 - S36. [Full Text] [PDF] |
||||
![]() |
S. Mesaros, M. A. Rocca, M. Absinta, A. Ghezzi, N. Milani, L. Moiola, P. Veggiotti, G. Comi, and M. Filippi Evidence of thalamic gray matter loss in pediatric multiple sclerosis Neurology, March 25, 2008; 70(13_Part_2): 1107 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Fisniku, P. A. Brex, D. R. Altmann, K. A. Miszkiel, C. E. Benton, R. Lanyon, A. J. Thompson, and D. H. Miller Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis Brain, March 1, 2008; 131(3): 808 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Fossey, C. L. Vnencak-Jones, N. J. Olsen, S. Sriram, G. Garrison, X. Deng, P. S. Crooke III, and T. M. Aune Identification of Molecular Biomarkers for Multiple Sclerosis J. Mol. Diagn., April 1, 2007; 9(2): 197 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pagani, R. Bammer, M.A. Horsfield, M. Rovaris, A. Gass, O. Ciccarelli, and M. Filippi Diffusion MR Imaging in Multiple Sclerosis: Technical Aspects and Challenges AJNR Am. J. Neuroradiol., March 1, 2007; 28(3): 411 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Frohman, E. Havrdova, F. Lublin, F. Barkhof, A. Achiron, M. K. Sharief, O. Stuve, M. K. Racke, L. Steinman, H. Weiner, et al. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis. Arch Neurol, April 1, 2006; 63(4): 614 - 619. [Full Text] [PDF] |
||||
![]() |
E. M. Frohman, O. Stuve, E. Havrdova, J. Corboy, A. Achiron, R. Zivadinov, P. S. Sorensen, J. T. Phillips, B. Weinshenker, K. Hawker, et al. Therapeutic Considerations for Disease Progression in Multiple Sclerosis: Evidence, Experience, and Future Expectations Arch Neurol, October 1, 2005; 62(10): 1519 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gallo, M. Rovaris, R. Riva, A. Ghezzi, B. Benedetti, V. Martinelli, A. Falini, G. Comi, and M. Filippi Diffusion-Tensor Magnetic Resonance Imaging Detects Normal-Appearing White Matter Damage Unrelated to Short-term Disease Activity in Patients at the Earliest Clinical Stage of Multiple Sclerosis Arch Neurol, May 1, 2005; 62(5): 803 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sisto, M. Trojano, M. Vetrugno, T. Trabucco, G. Iliceto, and C. Sborgia Subclinical Visual Involvement in Multiple Sclerosis: A Study by MRI, VEPs, Frequency-Doubling Perimetry, Standard Perimetry, and Contrast Sensitivity Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1264 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
G R W. Moore MRI Correlates of MS Pathologic Subtypes Multiple Sclerosis, February 1, 2005; 11(1): 103 - 105. [PDF] |
||||
![]() |
L M. Grimaldi, A Pincherle, F Martinelli-Boneschi, M Filippi, F Patti, A Reggio, D Franciotta, L Allegra, G Comi, and F Blasi An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients Multiple Sclerosis, October 1, 2003; 9(5): 467 - 471. [Abstract] [PDF] |
||||
![]() |
E. M. Frohman, D. S. Goodin, P. A. Calabresi, J. R. Corboy, P. K. Coyle, M. Filippi, J. A. Frank, S. L. Galetta, R. I. Grossman, K. Hawker, et al. The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology, September 9, 2003; 61(5): 602 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
M R Piras, I Magnano, E D G Canu, K S Paulus, W M Satta, A Soddu, M Conti, A Achene, G Solinas, and I Aiello Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 878 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y P Jin, J de Pedro-Cuesta, Y H Huang, and M Soderstrom Predicting multiple sclerosis at optic neuritis onset Multiple Sclerosis, April 1, 2003; 9(2): 135 - 141. [Abstract] [PDF] |
||||
![]() |
H. McFarland, F. Barkhof, J. Antel, and D. Miller The role of MRI as a surrogate outcome measure in multiple sclerosis Multiple Sclerosis, September 1, 2002; 8(1_suppl): 40 - 51. [Abstract] [PDF] |
||||
![]() |
M. Rovaris, M. Holtmannspotter, M. Rocca, G. Iannucci, M. Codella, B. Viti, A. Campi, G. Comi, T. Yousry, and M. Filippi Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study Multiple Sclerosis, September 1, 2002; 8(1_suppl): 52 - 58. [Abstract] [PDF] |
||||
![]() |
P Kapeller, P A Brex, D Chard, C Dalton, C M Griffin, M A McLean, G J. Parker, A J Thompson, and D H Miller Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis Multiple Sclerosis, June 1, 2002; 8(3): 207 - 210. [Abstract] [PDF] |
||||
![]() |
C M Griffin, J Dehmeshki, D T Chard, G J. Parker, G J Barker, A J Thompson, and D H Miller T1 histograms of normal-appearing brain tissue are abnormal in early relapsing-remitting multiple sclerosis Multiple Sclerosis, June 1, 2002; 8(3): 211 - 216. [Abstract] [PDF] |
||||
![]() |
H F McFarland, F Barkhof, J Antel, and D H Miller The role of MRI as a surrogate outcome measure in multiple sclerosis Multiple Sclerosis, February 1, 2002; 8(1): 40 - 51. [Abstract] [PDF] |
||||
![]() |
M Rovaris, M Holtmannspotter, M A Rocca, G Iannucci, M Codella, B Viti, A Campi, G Comi, T A Yousry, and M Filippi Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study Multiple Sclerosis, February 1, 2002; 8(1): 52 - 58. [Abstract] [PDF] |
||||
![]() |
J Palace MAKING THE DIAGNOSIS OF MULTIPLE SCLEROSIS J. Neurol. Neurosurg. Psychiatry, December 1, 2001; 71(suppl_2): ii3 - ii8. [Full Text] [PDF] |
||||
![]() |
F Patti, M L Cataldi, F Nicoletti, E Reggio, A Nicoletti, and A Reggio Combination of cyclophosphamide and interferon-{beta} halts progression in patients with rapidly transitional multiple sclerosis J. Neurol. Neurosurg. Psychiatry, September 1, 2001; 71(3): 404 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Hynson, A.J. Kornberg, L.T. Coleman, L. Shield, A.S. Harvey, and M.J. Kean Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children Neurology, May 22, 2001; 56(10): 1308 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Brex, S. M. Leary, G. T. Plant, A. J. Thompson, and D. H. Miller Magnetization Transfer Imaging in Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis AJNR Am. J. Neuroradiol., May 1, 2001; 22(5): 947 - 951. [Abstract] [Full Text] |
||||
![]() |
P A Brex, K A Miszkiel, J I O'Riordan, G T Plant, I F Moseley, A J Thompson, and D H Miller Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI J. Neurol. Neurosurg. Psychiatry, March 1, 2001; 70(3): 390 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rovaris, M. Bozzali, G. Santuccio, G. Iannucci, M. P. Sormani, B. Colombo, G. Comi, and M. Filippi Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis J. Neurol. Neurosurg. Psychiatry, December 1, 2000; 69(6): 723 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Dale, C. de Sousa, W. K. Chong, T. C. S. Cox, B. Harding, and B. G. R. Neville Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children Brain, December 1, 2000; 123(12): 2407 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. W. Moore, E. Leung, A. L. MacKay, I. M. Vavasour, K. P. Whittall, K. S. Cover, D. K. B. Li, S. A. Hashimoto, J. Oger, T. J. Sprinkle, et al. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain Neurology, November 28, 2000; 55(10): 1506 - 1510. [Abstract] [Full Text] [PDF] |
||||
![]() |
C M Griffin, G J. Parker, G J Barker, A J Thompson, and D H Miller MTR and T1 provide complementary information in MS NAWM, but not in lesions Multiple Sclerosis, October 1, 2000; 6(5): 327 - 331. [Abstract] [PDF] |
||||
![]() |
L. D. Jacobs, R. W. Beck, J. H. Simon, R. P. Kinkel, C. M. Brownscheidle, T. J. Murray, N. A. Simonian, P. J. Slasor, A. W. Sandrock, and The CHAMPS Study Group Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis N. Engl. J. Med., September 28, 2000; 343(13): 898 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Leocani, T. Locatelli, V. Martinelli, M. Rovaris, M. Falautano, M. Filippi, G. Magnani, and G. Comi Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 192 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Caruana, M. B. Davies, S. J. M. Weatherby, R. Williams, N. Haq, D. H. Foster, and C. P. Hawkins Correlation of MRI lesions with visual psychophysical deficit in secondary progressive multiple sclerosis Brain, July 1, 2000; 123(7): 1471 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tintoré, A. Rovira, M. J. Martínez, J. Rio, P. Díaz-Villoslada, L. Brieva, C. Borrás, E. Grivé, J. Capellades, and X. Montalban Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 702 - 706. [Abstract] [Full Text] |
||||
![]() |
M. Rovaris, M. Filippi, L. Minicucci, G. Iannucci, G. Santuccio, F. Possa and, and G. Comi Cortical/Subcortical Disease Burden and Cognitive Impairment in Patients with Multiple Sclerosis AJNR Am. J. Neuroradiol., February 1, 2000; 21(2): 402 - 408. [Abstract] [Full Text] |
||||
![]() |
A. Rovira, J. Alonso, G. Cucurella, C. Nos, M. Tintoré, S. Pedraza, J. Rio, and X. Montalban Evolution of Multiple Sclerosis Lesions on Serial Contrast-Enhanced T1-Weighted and Magnetization-Transfer MR Images AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1939 - 1945. [Abstract] [Full Text] |
||||
![]() |
D. M. Moriarty, A. J. Blackshaw, P. R. Talbot, H. L. Griffiths, J. S. Snowden, V. F. Hillier, S. Capener, R. D. Laitt, and A. Jackson Memory Dysfunction in Multiple Sclerosis Corresponds to Juxtacortical Lesion Load on Fast Fluid-Attenuated Inversion-Recovery MR Images AJNR Am. J. Neuroradiol., November 1, 1999; 20(10): 1956 - 1962. [Abstract] [Full Text] |
||||
![]() |
P. A. Brex, J. I. O'Riordan, K. A. Miszkiel, I. F. Moseley, A. J. Thompson, G. T. Plant, and D. H. Miller Multisequence MRI in clinically isolated syndromes and the early development of MS Neurology, October 1, 1999; 53(6): 1184 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
W I McDonald Physicians, subsequence and consequence J. Neurol. Neurosurg. Psychiatry, September 1, 1999; 67(3): 282 - 289. [Full Text] |
||||
![]() |
I. Nakashima, K. Fujihara, N. Okita, S. Takase, and Y. Itoyama Clinical and MRI study of brain stem and cerebellar involvement in Japanese patients with multiple sclerosis J. Neurol. Neurosurg. Psychiatry, August 1, 1999; 67(2): 153 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tourbah, O. Gout, R. Liblau, O. Lyon-Caen, C. Bougniot, M. T. Iba-Zizen, and E. A. Cabanis Encephalitis after hepatitis B vaccination: Recurrent disseminated encephalitis or MS? Neurology, July 1, 1999; 53(2): 396 - 396. [Abstract] [Full Text] |
||||
![]() |
P. Sarchielli, O. Presciutti, G. P. Pelliccioli, R. Tarducci, G. Gobbi, P. Chiarini, A. Alberti, F. Vicinanza, and V. Gallai Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients Brain, March 1, 1999; 122(3): 513 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miki, R. I. Grossman, J. K. Udupa, M. A. van Buchem, L. Wei, M. D. Phillips, U. Patel, J. C. McGowan, and D. L. Kolson Differences between Relapsing-Remitting and Chronic Progressive Multiple Sclerosis as Determined with Quantitative MR Imaging Radiology, March 1, 1999; 210(3): 769 - 774. [Abstract] [Full Text] |
||||
![]() |
M. Sailer, J. I. O'Riordan, A. J. Thompson, D. P. Kingsley, D. G. MacManus, W. I. McDonald, and D. H. Miller Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination Neurology, February 1, 1999; 52(3): 599 - 599. [Abstract] [Full Text] |
||||
![]() |
S. J. Khoury and H. L. Weiner Multiple Sclerosis: What Have We Learned From Magnetic Resonance Imaging Studies? Arch Intern Med, March 23, 1998; 158(6): 565 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Sarchielli, O Presciutti, R Tarducci, G Gobbi, A Alberti, G P Pelliccioli, A Orlacchio, and V Gallai 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta -1a: results of a preliminary study J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 204 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P Ebmeier, N. Prentice, A. Ryman, E. Halloran, J E. Rimmington, J. K K Best, and G. M Goodwin Temporal lobe abnormalities in dementia and depression: a study using high resolution single photon emission tomography and magnetic resonance imaging J. Neurol. Neurosurg. Psychiatry, November 1, 1997; 63(5): 597 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Thomke, E. Lensch, K. Ringel, and H. C. Hopf Isolated cranial nerve palsies in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, November 1, 1997; 63(5): 682 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Hutchinson, T Burke, and M Hutchinson Neuropsychological assessment in multiple sclerosis: methodological issues and concerns Multiple Sclerosis, September 1, 1996; 2(2): 57 - 65. [Abstract] [PDF] |
||||
![]() |
D. Miller Guidelines for MRI monitoring of the treatment of multiple sclerosis: recommendations of the US Multiple Sclerosis Society's task force Multiple Sclerosis, June 1, 1996; 1(6): 335 - 338. [Abstract] [PDF] |
||||
![]() |
J. L. Keltner, C. A. Johnson, J. O. Spurr, R. W. Beck, and Optic Neuritis Study Group Visual Field Profile of Optic Neuritis: One-Year Follow-up in the Optic Neuritis Treatment Trial Arch Ophthalmol, July 1, 1994; 112(7): 946 - 953. [Abstract] [PDF] |
||||
![]() |
D. E. Goodkin, R. A. Rudick, and J. S. Ross The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis Arch Neurol, May 1, 1994; 51(5): 505 - 516. [Abstract] [PDF] |
||||
![]() |
J. Pelletier, M. Habib, O. Lyon-Caen, G. Salamon, M. Poncet, and R. Khalil Functional and Magnetic Resonance Imaging Correlates of Callosal Involvement in Multiple Sclerosis Arch Neurol, October 1, 1993; 50(10): 1077 - 1082. [Abstract] [PDF] |
||||
![]() |
R. W. Beck, J. Arrington, F. R. Murtagh, P. A. Cleary, D. I. Kaufman, and Optic Neuritis Study Group Brain Magnetic Resonance Imaging in Acute Optic Neuritis: Experience of the Optic Neuritis Study Group Arch Neurol, August 1, 1993; 50(8): 841 - 846. [Abstract] [PDF] |
||||
![]() |
D. W. Paty, R. A. Koopmans, GuoJun Zhao, D. K.B. Li, J. J.F. Oger, and J. Petkau Magnetic Resonance Imaging (MRI) As an Outcome Measure in Multiple Sclerosis Neurorehabil Neural Repair, January 1, 1993; 7(3-4): 117 - 129. [PDF] |
||||
![]() |
R. Capra, N. Marciano, L. A. Vignolo, A. Chiesa, and R. Gasparotti Gadolinium--Pentetic Acid Magnetic Resonance Imaging in Patients With Relapsing Remitting Multiple Sclerosis Arch Neurol, July 1, 1992; 49(7): 687 - 689. [Abstract] [PDF] |
||||
![]() |
M. I. Chimowitz, M. L. Estes, A. J. Furlan, and I. A. Awad Further Observations on the Pathology of Subcortical Lesions Identified on Magnetic Resonance Imaging Arch Neurol, July 1, 1992; 49(7): 747 - 752. [Abstract] [PDF] |
||||
![]() |
W. A. Marks, R. M. Shuman, and J. B. Bodensteiner HLA Patterns in Children With Parainflammatory Leukoencephalomyelitis J Child Neurol, April 1, 1991; 6(2): 150 - 154. [Abstract] [PDF] |
||||
![]() |
S. D. Johnsen, A. D. Sidell, and C. R. Bird Subtle Encephalomyelitis in Children: A Variant of Acute Disseminated Encephalomyelitis J Child Neurol, July 1, 1989; 4(3): 214 - 217. [Abstract] [PDF] |
||||
![]() |
F. A. J. Muller, P. E. Hanny, W. Wichmann, W. Fierz, and M. R. Dursteler Cerebrospinal Fluid Immunoglobulins and Multiple Sclerosis: Correspondence With Magnetic Resonance Imaging and Visually Evoked Potential Changes Arch Neurol, April 1, 1989; 46(4): 367 - 371. [Abstract] [PDF] |
||||
![]() |
D. S. Younger, S. Chou, A. P. Hays, D. J. Lange, R. Emerson, M. Brin, H. Thompson Jr, and L. P. Rowland Primary Lateral Sclerosis: A Clinical Diagnosis Reemerges Arch Neurol, December 1, 1988; 45(12): 1304 - 1307. [Abstract] [PDF] |
||||
![]() |
W. A. Marks, J. B. Bodensteiner, G. B. Bobele, M. Hamza, and D. A. Wilson Parainflammator Leukoencephalomyelitis: Clinical and Magnetic Resonance Imaging Findings J Child Neurol, July 1, 1988; 3(3): 205 - 213. [Abstract] [PDF] |
||||
![]() |
J. C. J. Bot, F. Barkhof, G. L. a Nijeholt, D. van Schaardenburg, A. E. Voskuyl, H. J. Ader, J. A. L. Pijnenburg, C. H. Polman, B. M. J. Uitdehaag, E. G. J. Vermeulen, et al. Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging Radiology, April 1, 2002; 223(1): 46 - 56. [Abstract] [Full Text] [PDF] |
||||














